These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11514945)

  • 1. Interpretations of a teratogen warning symbol.
    Daniel KL; Goldman KD; Lachenmayr S; Erickson JD; Moore C
    Teratology; 2001 Sep; 64(3):148-53. PubMed ID: 11514945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining teratogen warning symbols for diverse populations.
    Mayhorn CB; Goldsworthy RC
    Birth Defects Res A Clin Mol Teratol; 2007 Jun; 79(6):494-506. PubMed ID: 17358036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory evaluation of several teratogen warning symbols.
    Goldsworthy R; Kaplan B
    Birth Defects Res A Clin Mol Teratol; 2006 Jun; 76(6):453-60. PubMed ID: 16933215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and improved: the role of text augmentation and the application of response interpretation standards (coding schemes) in a final iteration of birth defects warnings development.
    Mayhorn CB; Goldsworthy RC
    Birth Defects Res A Clin Mol Teratol; 2009 Oct; 85(10):864-71. PubMed ID: 19551714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of pharmaceutical warnings among adolescents.
    Goldsworthy RC; Schwartz NC; Mayhorn CB
    J Adolesc Health; 2008 Jun; 42(6):617-25. PubMed ID: 18486871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription of teratogenic medications in United States ambulatory practices.
    Schwarz EB; Maselli J; Norton M; Gonzales R
    Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Over the counter medication in pregnant women].
    Mikou S; Buire AC; Trenque T
    Therapie; 2008; 63(6):415-8. PubMed ID: 19236832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of pregnant women using isotretinoin.
    Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA; Paulozzi LJ; Erickson JD
    Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of prescription medications with a potential for fetal harm among pregnant women.
    Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suitability and readability of consumer medical information accompanying prescription medication samples.
    Wallace LS; Keenum AJ; Roskos SE; Blake GH; Colwell ST; Weiss BD
    Patient Educ Couns; 2008 Mar; 70(3):420-5. PubMed ID: 18178363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of symbols on the short-term recall of pharmacy-generated prescription medication information in a low health literate sample.
    King SR; McCaffrey DJ; Bentley JP; Bouldin A; Hallam J; Wilkin NE
    J Health Commun; 2012; 17 Suppl 3():280-93. PubMed ID: 23030576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome following exposure to permethrin and use of teratogen information.
    Kennedy D; Hurst V; Konradsdottir E; Einarson A
    Am J Perinatol; 2005 Feb; 22(2):87-90. PubMed ID: 15731987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical review of FDA-approved Medication Guides.
    Wolf MS; Davis TC; Shrank WH; Neuberger M; Parker RM
    Patient Educ Couns; 2006 Sep; 62(3):316-22. PubMed ID: 16884888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation.
    Brent RL
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):906-18. PubMed ID: 16206282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accutane-exposed pregnancies--California, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project.
    Felix RJ; Jones KL; Johnson KA; McCloskey CA; Chambers CD;
    Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):944-7. PubMed ID: 15570610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital outpatients' responses to taking medications with driving warnings.
    Smyth T; Sheehan M; Siskind V
    Traffic Inj Prev; 2013; 14(1):18-25. PubMed ID: 23259515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.